Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Venetoclax with Decitabine or Azacitidine in Relapsed or Refractory Acute Myeloid Leukemia.
Bouligny IM, Murray G, Ho T, Doyel M, Patel T, Boron J, Tran V, Gor J, Hang Y, Alnimer Y, Zacholski K, Venn C, Wages NA, Grant S, Maher KR. Bouligny IM, et al. Among authors: maher kr. Res Sq [Preprint]. 2023 Jun 12:rs.3.rs-3015916. doi: 10.21203/rs.3.rs-3015916/v1. Res Sq. 2023. Update in: EJHaem. 2023 Feb 24;4(2):381-392. doi: 10.1002/jha2.663. PMID: 37398154 Free PMC article. Updated. Preprint. No abstract available.
Abbreviated venetoclax with decitabine or azacitidine in acute myeloid leukemia.
Bouligny IM, Murray G, Ho T, Doyel M, Patel T, Boron J, Tran V, Gor J, Hang Y, Alnimer Y, Zacholski K, Venn C, Wages NA, Grant S, Maher KR. Bouligny IM, et al. Among authors: maher kr. Leuk Res. 2023 Nov;134:107370. doi: 10.1016/j.leukres.2023.107370. Epub 2023 Aug 16. Leuk Res. 2023. PMID: 37659346 No abstract available.
15 results